MyavA.00762.a: Short chain dehydrogenase
Target Characteristics
from organism: | Mycobacterium avium 104 |
most recent status: | soluble |
center reference id: | MyavA.00762.a |
is community request: | False |
associated disease: | Johne's disease, paratuberculosis |
NIH risk group: | 2 |
is select agent: | False |
NIH priority pathogens category: |
IIIC |
Ordering Clones & Proteins
If there are materials available for this target, they will be listed below.
Materials can be ordered from SSGCID using the button in the "order material" column.
Clicking the button will add the material to a virtual cart.
You may order multiple materials at a time at no cost to you, as this contract is funded
by NIAID. When you are ready to place your order, click the "Place Order" link which will
appear in the top right corner of the page after you place your first item in your cart.
Clones*
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
MyavA.00762.a.A1.GE29016 | Full length( MyavA.00762.a ) | 1 | 262 | GE29016 |
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information
using the button in the "info" column.
External Resources
Resource | Reference ID |
---|---|
OrthoMCL: | OG5_168406 |
PATRIC ID: | fig|243243.7.peg.583 |
RefSeq: | YP_879882.1 |
UniProt: | A0A0H3A422 |
Enzyme & Pathway Information
Pathway | Pathway ID | EC Number |
---|---|---|
biotin biosynthesis I | BIOTIN-BIOSYNTHESIS-PWY | 1.1.1.100 |
(5Z)-dodecenoate biosynthesis I | PWY0-862 | 1.1.1.100 |
superpathway of fatty acid biosynthesis I (E. coli) | PWY0-881 | 1.1.1.100 |
arachidonate biosynthesis | PWY-5353 | 1.1.1.100 |
petroselinate biosynthesis | PWY-5367 | 1.1.1.100 |
cis-vaccenate biosynthesis | PWY-5973 | 1.1.1.100 |
superpathway of mycolate biosynthesis | PWY-6113 | 1.1.1.100 |
palmitoleate biosynthesis I (from (5Z)-dodec-5-enoate) | PWY-6282 | 1.1.1.100 |
superpathway of unsaturated fatty acids biosynthesis (E. coli) | PWY-6284 | 1.1.1.100 |
superpathway of fatty acids biosynthesis (E. coli) | PWY-6285 | 1.1.1.100 |
8-amino-7-oxononanoate biosynthesis I | PWY-6519 | 1.1.1.100 |
eicosapentaenoate biosynthesis from arachidonate | PWY-6940 | 1.1.1.100 |
docosahexanoate biosynthesis II | PWY-6951 | 1.1.1.100 |
docosahexanoate biosynthesis I | PWY-7053 | 1.1.1.100 |
gondoate biosynthesis (anaerobic) | PWY-7663 | 1.1.1.100 |
oleate biosynthesis IV (anaerobic) | PWY-7664 | 1.1.1.100 |
(5Z)-dodecenoate biosynthesis II | PWY-7858 | 1.1.1.100 |
mycolate biosynthesis | PWYG-321 | 1.1.1.100 |
Sequences
These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols.
To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MSLSEAPKEI AGHGLLEGKV VIVTAAAGTG IGSATAKRAL AEGADVVISD HHERRLGETA DQLAALGQGR VESVLCDVTS TAQVDALFAS AHARMGRIDV LVNNAGLGGQ TPVVDMTDDE WDRVLDVTLT SVFRATRAAL RYFRDAPHGG VIVNNASVLG WRAQHSQSHY AAAKAGVMAL TRCSAIEAAE YDVRINAVSP SIARHKFLEK TSSADLLDRL SAGEAFGRAA EPWEVAATIA FLASDYSSYL TGEVISVSSQ HP
NT Sequence
ATGAGCCTGT CCGAAGCTCC GAAAGAGATT GCGGGACACG GGCTTCTGGA AGGCAAGGTG GTGATCGTCA CCGCGGCGGC CGGCACGGGT ATCGGCTCGG CGACGGCCAA ACGAGCGCTC GCCGAGGGCG CCGACGTGGT GATCTCCGAC CACCACGAGC GTCGGCTGGG CGAGACCGCC GACCAGCTCG CGGCGCTCGG CCAGGGCCGG GTGGAAAGCG TGCTGTGCGA CGTGACGTCC ACCGCCCAGG TCGATGCGCT GTTCGCGTCG GCCCACGCGC GGATGGGGCG CATCGACGTG CTGGTCAACA ACGCCGGGCT GGGCGGGCAG ACCCCGGTGG TCGACATGAC CGACGACGAG TGGGACCGGG TGCTCGATGT CACCCTGACC TCGGTTTTCC GCGCCACCCG TGCCGCGCTG CGCTACTTCC GCGACGCGCC GCACGGCGGG GTGATCGTCA ACAACGCCAG CGTGCTGGGC TGGCGGGCGC AGCACTCCCA GTCGCACTAC GCCGCCGCCA AGGCCGGGGT GATGGCGTTG ACCCGGTGCA GCGCAATCGA AGCCGCCGAG TACGACGTGC GGATCAACGC GGTGTCGCCG AGCATCGCCC GGCACAAGTT CCTGGAGAAG ACGTCGTCGG CCGACCTGCT CGACCGGCTC TCGGCCGGTG AGGCGTTCGG TCGCGCCGCC GAGCCCTGGG AGGTCGCGGC CACCATCGCG TTTTTGGCCA GCGACTACTC CAGCTACCTG ACCGGCGAGG TCATCTCGGT GTCCAGCCAG CATCCG